EASL Clinical Practice Guidelines

Future investigations

Randomized trials are urgently needed to assess the efficacy/safety especially of LMWH, VKA and DOAC in cirrhosis. Alternative laboratory monitoring should be developed and validated in cirrhotic patients treated with LMWH or VKA.